CEO & FOUNDER
Echo is on a mission to make technology accessible by bridging the gap between U.S. companies and Chinese corporations and investors. She is unique in that she has 15 years of experience in cross-border transactions for fortune global companies, such as IBM, Lenovo and J&J. In recent years, she has also successfully founded a number of consumer goods and education companies. She holds an MBA from Duke and the FINRA Series 7, 63 and 79 securities licenses.
Marc has over 20 years experience initially as a sell-side senior equity research analyst at Citigroup and subsequently as an investment banker at various institutions on Wall Street. Marc's past transaction experience focuses on tech, internet of things, robotics/AI, telecom-media, & consumer goods. He received an MBA from Stern NYU and a BS in Economics from Binghamton.
JOHN MEI, MD, PhD
SENIOR PARTNER, HEALTHCARE
Over 20 years experience as a pharmacologist and clinical trial expert. His experiences include new drug development and commercialization, medical affair and field based medicine. Previously he was a senior medical director at Baxter Healthcare. He also founded Synature Pharmaceutical, Claymore Technologies and Panax Pharmaceuticals and owns 4 patents and marketing rights. He holds an M.D. from Cornell University and received Post-doc training at Yale University.
Romain received his LLM in France in 1995 before moving to China in 1997. He holds an EMBA and PhD in management. Fluent Chinese speaker, he has helped many Fortune 500 companies in cross -border deals, setting up their operation and/or building their infrastructure in China. His portfolio includes companies from automotive, biopharmaceutical, IT, F&B, chemical industries among others. He currently resides in Shanghai, China.
The Executive Director, Co-President, and Co-Founder of COAMC International. Ludwig has over 35 years of international M&A execution and advisory experience across Asia, Africa, Latin America, EU and USA accumulated through major international investment banks, supranational institutions and PRC financial institutions including JPM, UBS and China Construction Bank. He received his MBA and BS in MIT.
JOHN T. KONTHER
Over 40 year experience as a senior partner in a number of law firms including Hunton & Williams and Conboy, Hewitt O’Brien & Boardman. Served as investment counsel for a number of large corporate investment committees managing retirement savings investment. JD from Brooklyn Law School and Masters of Law from New York University.
SENIOR PARTNER, CHINA
Rong's most recent experience includes working as senior vice president at corporate finance group in Everbright, one of the largest financial conglomerates in China. His clients are mostly large public listed companies in China. Prior to Everbright, he has over 10 years of experience working as a senior editor and journalist at China Southern Newspaper. Rong receives his MBA from Hong Kong Space and BS from Nan Chang University.
LIGUO ZHANG, PhD
SENIOR ADVISOR, HEALTHCARE
Currently the Director of Research at Chinese Academy of Science’s Institute of Biophysics. He is a key opinion leader in areas of diseases and infections such as HIV, HBV and HCV. Previously, he served as a post doctor associate at Yale University and the University of North Carolina. He holds an MS in Veterinary Microbiology and Immunology from Nanjing Agricultural University and a Ph.D. in Virology from the Chinese Academy of Preventive Medicine.
SENIOR ADVISOR, TECHNOLOGY
CFO and a Director of Apowa Networks, a public listed mobile/VR gaming company (ticker: 833765) in China. Prior to Apowa, Ke was a portfolio manager at Milestone Capital, a Shanghai-based PE fund with AUM of $1 billion. From 2004 to 2008, Ke was a senior investment banker at CICC (one of the largest investment banks in China) focusing on IPO and M&A transactions. Ke received an MBA from INSEAD and B.A. in Singapore Management University.
SENIOR ADVISOR, HEALTHCARE IT
CEO of Dabai Doctor, a nationwide mobile on-demand family doctor network in China with over 1,000 doctors. Prior to Dabai, Kitty was a senior portfolio manager at Lightspeed China Partners. Prior to Lightspeed, she has over a decade of experience in corporate finance, internationals transactions, and audit services in China working with companies across all sectors from clean tech to healthcare. Kitty holds an MBA from Duke
IVAN KING, PhD
SENIOR ADVISOR, HEALTHCARE
Previously Senior VP of Pre-Clinical Development at BeiGene, VP of R&D of Vion Pharma, Section Leader in Schering-Plough Research Institute, and Senior Scientist in Bristol-Myers Squibb. 50 manuscripts coauthored and 40+ patents. Ph.D. from University of Texas and postdoc training from Yale. B. Sc. and M. Ph. degrees from The Chinese University of Hong Kong.